ThermoGenesis

Feb 19, 2020

ThermoGenesis Holdings Announces Partial Conversion Of Revolving Credit Agreement Held By Boyalife Asset Holding II

Jan 03, 2020

ThermoGenesis Holdings Announces That ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment

Nov 12, 2019

ThermoGenesis Holdings To Delay Third Quarter 2019 Earnings Release And Conference Call Until Thursday, November 14, 2019

Nov 06, 2019

ThermoGenesis Holdings To Announce Financial Results For The Third Quarter Ended September 30, 2019 And Provide A Corporate Strategic Update

Sep 09, 2019

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products

Aug 13, 2019

Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update

Jul 23, 2019

America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II System

Jun 05, 2019

ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium

Feb 25, 2019

ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells

Feb 01, 2019

ThermoGenesis Corp Signs Strategic Supply Agreement with Orthohealing Center Management to Provide it's PXP® Point-of-Care System to Orthohealing Method(TM) Physician Members

Nov 13, 2018

Cesca Therapeutics Submits Device Master File (MAF) with the FDA for the X-LAB® Automated Cell Processing Devices